glp 1 and dental issues Ozempic Teeth': GLP-1 Drugs May Cause Tooth Decay, Experts Say Ozempic teeth | Dentist in

The latest data shows that 1 in 8 Americans have used a GLP-1, with ~15 million currently using them

Retrieved from Medhi et al

Practitioners should be aware of this evidence gap when discussing the treatment with patients

Patel, F., Gan, A., Chang, K., & Vega, K

Last month (May 2025), Novo Nordisk and Septerna, a San Francisco, California-based bio/pharmaceutical company focused on GCPRs, formed an exclusive global collaboration and license agreement to discover, develop, and commercialize oral small-molecule medicines for treating obesity, Type 2 diabetes, and other cardiometabolic diseases, in a deal worth up to $2.2 billion ($200 million upfront and near-term funding and $2 billion in milestone payments)

A licensed clinician reviews it and, if you qualify, issues a prescription